More on SCNX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.41 |
|
|||
| Open | $0.39 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.42 | ||||
| Day Low | $0.39 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 445,356 | ||||
- Scienture to ship naloxone nasal spray to wholesalers in July
- SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers
- Scienture adds 12.5 million covered lives for Arbli payor network
- SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
- SCIENTURE adds REZENOPY nasal spray to major health plan formulary
- SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team
- SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC
- SCIENTURE receives patent for naloxone nasal spray through 2041
- SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
- Form 8-K Scienture Holdings, Inc. For: May 26
Entities mentioned with SCNX
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- S3 | View Related Stories »
- Show More...
